Pfizer, Mylan Await Decision In Norvasc Patent Case
Now that the trial before Judge Terrence F. McVerry of the U.S. District Court
Western District of Pennsylvania has wrapped up, both parties await a decision as to whether or not Mylan can sell a generic version of Norvasc.
Pfizer received Norvasc’s patent in 1987, and it is set to expire...
To view the full article, register now.